|
Publicaciones Médicas 2006/ 2010
2010
Pavlovsky S, Remaggi G. “Trasplante de células hematopoyéticas para el tratamiento del linfoma no Hodgkin”. Revista Argentina de Trasplantes Nº 1 Vol 2, 2010.
2009
Basquiera AL, Soria NW, Ryser R, Salguero M, Moiraghi B, Sackmann F, Sturich AG, Borello A, Berretta A, Bonafé M, Barral JM, Palazzo ED, García JJ. “Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders”. Hematology. Dec;14(6):323-30, 2009.
Pavlovsky C, Kantarjian H, Cortés J. “First-line therapy for chronic myeloid leukemia: past, present, and future”. Am J Hematol. Feb 19; 84 (5) 287-293, 2009.
Montesinos P, Diaz Mediavilla J, Deben G, Prates V, Tormo M, Rubio V, Perez I, Fernandez I, Viguria M, Rayon C, Gonzalez J, Negri S, Brunet S, Lowenberg B, Sanz MA. “Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis. Haematologica 94 (9), 2009.
Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart K, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Dabies F, Cheng-Kiang S, Durie BGM, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loi H. International Myeloma Working Group (IMWG) molecular classification of multiple myeloma: Spotlight review. Leukemia 1-2, 2009 (Dr. S. Pavlovsky is a member of this group)
Pavlovsky C, Egorin MJ, Shah DD, Beumer JH, Rogel S, Pavlovsky S. Imatinib mesylate pharmacokinetics before and after sleeve gastrectomy in a morbidly obese patient with chronic myeloid leukemia. Pharmacotherapy, Sept; 29(9):1152-6, 2009.
Pavlovsky S. Nuevos inhibidores de la tirosina-quinasa en la leucemia mieloide crónica en fase crónica. Revista de Hematología. (Agrupación Mexicana para el Estudio de la Hematología) Capítulo 16, Vol 10, Suplem. 3, Abril 2009.
Pavlovsky S. Progresos en el tratamiento del Linfoma de Hodgkin, en las últimas cuatro décadas. Experiencia Argentina del Grupo Argentino de Tratamiento de Leucemia Aguda (GATLA). Revista de Hematología. (Agrupación Mexicana para el Estudio de la Hematología). Capítulo 9, Vol 10, Suplem 3, Abril 2009.
Curcio D, Barcelona L.I, Cornistein W, Bantar C, Barcan L, Bonvehi P, Reina R, Bergallo C, Biondi H, Calderón J, Castagnino J, Chinchilla P, Dignani M.C, Esposto A, Falcón Pérez N, Freuler C, Luna C.M, Ríos F, Rodriguez C, Valentini R, Vazquez W, Verbanaz S, Vergara G. Current Rational to Prescribe Tigecycline: Critical Analysis of the Evidence and Usage Algorithms by an Argentinean Experts Panel. Clinical Medicine: Therapeutics1 1–16, 2009.
Kumar S, Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger W, Comenzo R, Lentzsch S, Munshi N, Niesvizky R, San Miguel J, Ludwig H, Bergsagel L, Blade J, Lonial S, Anderson K, Tosi P, Sonneveld P, Sezer O, Vesole D, Cavo M, Einsele H, Richardson P, Durie B, Rajkumar SV, on behalf of the IMWG. (Dr. S. Pavlovsky es miembro del International Myeloma Working Group). Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide, lenalidomide or bortezomib – containing regimens. Blood 114:1729-1735, 2009.
Sackmann, F, Pavlovsky S. Myelodysplastic syndrome and pregnancy: Case Report. Leukemia Research 33 pp e23-e25, 2009.
Montesinos P, Verruga JM, Vellenga E, Rayón C, Parody R, de la Serna J, León A, Esteve J, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA.Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans-retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood 113: 775–783, 2009.
Alejandre M, Pavlovsky MA, Corrado C, Madalena L, Facio ML, Bresciani P, Juni M, Pavlovsky A, Sackmann F, Pavlovsky S, Pizzolato M. “Trasplante autólogo de médula ósea en mieloma múltiple: 15 años de experiencia en el control de evolución grado de respuesta y detección de perfiles proteicos atípicos”. Revista “Hematología” de la Sociedad Argentina de Hematología. Vol 13 Nº 1 – Enero-Abril 2009
Dimopoulos M, Terpos E, Comenzo RL, Tosi P, Beksac M, Sezer O, Siegel D, Lokhorst H, Kumar S, Rajkumar SV, Niesvizky R, Moulopoulos LA, Durie BGM. On behalf of the IMWG (International Myeloma Working Group) (Dr. Pavlovsky es miembro de este grupo). International myeloma working group consensus statement and guidelines regarding the current role of imagining techniques in the diagnosis and monitoring of multiple myeloma. Leukemia. Review 1-12, 2009.
Hari P, Zhang MJ, Perez WS, Bashey A, Bik TL, Elfenbein G, Freytes CO, Gale RP, Gibson J, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Pavlovsky S, Reece DE, Schiller G, Vela Ojeda J, Weisdorf D, Vesole D. Is the International staging system superior to the Durie Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia 23, 1528-1534, 2009.
Ferro H, Juni M, Bello R, Vidal A, Diez R, Pavlovsky S.”Utilization study of Filgrastim (Neutromax) during autologous hematopoietic precursor transplantation for myeloma and lymphoma patients”. Transfusion and Apheresis Science 41:87-93, 2009.
Palumbo A, Sezer O, Kyle R, San Miguel J, Orlowsky R, Moreau P, Niesvizky R, Morgan G, Comenzo R, Sonneveld P, Kumar S, Hajek R, Giralt S, Bringhen S, Anderson K, Richardson G, Cavo M, Davies F, Blade J, Einsele H, Dimopoulos MA, Spencer A, Dispenzieri A, Reiman R, Shimizu K, Lee J, Attal M, Boccadoro M, Mateos M, Chen W, Ludwig H, Joshua D, Chim J, Hungria V, Turesson I, Durie BGM and
Lonial S on behalf of the IMWG. (Dr. S. Pavlovsky es miembro del International Myeloma Working Group) International Myeloma Working Group guidelines for the management of multiple myeloma patients inelegible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia (4/6/09 published on line.)(En prensa).
Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger W, Comenzo RL, Kumar S, Munshi NC, Dispenzieri A, Kyle B, Merlini G, San Miguel J, Ludwig H, Hajek R, Jagannath S, Blade J, Lonial S, Dimopoulos MA, Ensele H, Barlogie B, Anderson KC, Gertz M, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Richardson, Niesvizky R, Rajkumar SV and Durie BGM on behalf of the IMWG (Dr. S. Pavlovsky es miembro del International Myeloma Working Group). International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100). Leukemia 1-9 (2009) – advanced publication June 25, 2009.(En prensa).
Kyle RA, Durie BGM, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole D, Dimopoulos M, San-Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson P, Barlogie B,Vescio R, Turesson I, Westin J, Boccadoro M. “Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering (Asymptomatic) Multiple Myeloma: IMWG Consensus Perspectives Risk Factors for Progression and Guidelines for Monitoring and Management”. (En prensa) (Sent to Blood)
Lazarus HM, Zhang MJ, Carreras J, Hayes Lattin BM, Ataergim AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD, Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM and Hari PN. “A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large b-cell lymphoma: a report from the CIBMTR. (En prensa) (Enviado a Biol Blood Marrow Transplant).
Dispenzieri A, Kyle R. Merlini G, San Miguel J, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Rajkumar SV and Durie BMG, on behalf of the International Myeloma Working Group (Dr. Pavlovsky is a member of this group) “International Myeloma Working Group guidelines for serum free light chain analysis in multiple myeloma and related disorders” (Aceptado para Revista Leukemia)
2008
Sackmann F, Pavlovsky MA, Corrado C, Pizzolato M, Alejandre M, Pavlovsky S. Prognostic factors in monoclonal gammopathy of undetermined significance. Haematologica Jan 93(1):153-4, 2008
Dignani MC. Actualizaciones sobre vacunas 2008. En colaboración con la Comisión de Vacunas de la SADI. 2008.
San Miguel J, Schlag R, Khuageva N, Dimopoulos M, Shpilberg O, Kropff M, Spicka I, Petrucci M, Palumbo A, Samoilova O, Dmoszynska A, Abdulkadyrov K, Schots R, Jiang B, Mateos MV, Anderson K, Esseltine D, Liu K, Cakana A, van de Velde H, Richardson P. “Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma”. N Eng J Med 359; 906-917, 2008. (S. Pavlovsky es parte del Grupo de Investigadores del Protocolo VISTA).
Pavlovsky S. “Utilidad del PET TC en el estudio y tratamiento de los linfomas”. Hematología, Vol 12 Nº 2:53-54. Mayo-Agosto 2008.
Alfonso G, Basso A, Bullorsky E, García JJ, Labanca V, Lopez I, Maidana M, Pavlovsky S. Utilización de recursos sanitarios para tratar la Leucemia Mieloide Crónica en Argentina. Los resultados de una reunión de consenso de especialistas en Hematología. Hematología Vol 12 Nº 2: 35-42. Mayo-Agosto 2008.
Pavlovsky C, Pardo L, Pavlovsky MA, Corrado C, Sapia S, Mountford P, Monreal M, Fernandez I, Milone G, Pavlovsky A, Juni M, Pavlovsky S. “Is assessment of surface CD38 expression worthwhile as a prognostic factor in chronic lymphocytic leukemia patients?”, Hematology 13 Nº 1, 24-27, 2008.
Dignani MC. “Tratamiento de Candidiasis Invasiva”, en: Guías de recomendaciones sobre Diagnóstico, Tratamiento y Prevención de Infecciones en Pacientes con Cáncer. Consenso de la Sociedad Argentina de Infectología (SADI). Comisión de Infecciones en la Paciente Neoplásico y Trasplantado de Medula Ósea. Buenos Aires. Pag. 87, 2008.
Dignani MC. “Profilaxis antifúngica secundaria. Tratamiento de Candidiasis Invasiva”. en: Guías de recomendaciones sobre Diagnóstico, Tratamiento y Prevención de Infecciones en Pacientes con Cáncer. Consenso de la Sociedad Argentina de Infectología (SADI). Comisión de Infecciones en la Paciente Neoplásico y Trasplantado de Medula Ósea. Buenos Aires. Pag. 113, 2008.
Olson JA, Adler-Moore JP, Jensen GM, Schwatz J, Dignani MC, Proffitt RT. “Comparison of the physicochemical, antifungal and toxic properties of two liposomal amphotericin B Products. Antimicrobial Agents and Chemotherapy: Pag. 259-268, 2008.
Rivas MA, Carnevale RP, Proietti CH, Rosemblit C, Beguelin W, Salatino M, Charreau EH, Frahm I, Sapia S, Brouckaert P, Elizalde PV, Schillaci R. “TNF alpha acting on TNFR1 promotes breast cancer growth via P42/p44 MAPK, JNK, Akt and NF-kappa B-dependent patways”. Exp Cell Res 2008 Feb 1;3 14 (3): 509-29 Epub 2007 Oct 13.
Zanetto U, Dong H, Huang Y, Zhang K, Narbaitz M, Sapia S, Kostopoulos I, Liu H, Du MQ, Bacon CM. “Mantle Cell Lymphoma with Aberrant Expression of CD10”. Histopathology, Jan 2008.
Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn J-Y, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G,
Keating A, Loberiza FR, Giralt S, Horowitz MM, Weisdorf DJ. “Long-term outcomes of adults with acute lymphoblastic leucemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research”. B Marrow Transplant 41, 635-642, 2008.
Husseins MA, Vrionis FD, Allison R, Berenson J, Berven S, Erdem E, Giralt S, Jagannath S, Kyle RA, Le Grand S, Pflugmacher R, Raje N, Rajkumar S, Randall L, Roodman D, Siegel D, Vescio R, Zonder J, Durie BGM, on behalf of the International Myeloma Working Group. “The role of vertebral augmentation in multiple myeloma”: International Myeloma Working Group Consensus Statement. Leukemia 1-6 (2008) Keynote Address. (Dr. Pavlovsky es miembro de este grupo)
Lazarus H, Carreras J, Boudreau C, Loberiza F, Armitage J, Bolwell B, Freytes C, Gale R, Ghibson J, Hale G, Inwards D, LeMaistre Ch, Maharaj, Marks D, Miller A, Pavlovsky S, Schouten HC, Van Besie K, Vose JM, Rizzo JD. “Influence of age and histology on outcome in adult non Hodgkin lymphoma patients undergoing autologous HCT: A report from the Center for International Blood & Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 14:1323-1333,2008.
Sanz MA, Montesinos P, Vellenga E, Rayón C, de la Serna J, Parody R, Verruga JM, León A, Negri S, González M, Rivas C, Esteve J, Milone G, González JD, Amutio E, Brunet S, García-Laraña J, Colomer D, Calasanz MJ, Chillón C, Barragán E, Bolufer P, Lowenberg B. “Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group”. Blood 112: 3130-3134, 2008.
de la Serna J, Montesinos P, Vellenga E, Rayón C, Parody R, León A, Esteve J, Verruga JM, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA. “Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin”. Blood 111: 3395–3402, 2008.
Kumar S, Pérez W, Zhang MJ, Bredeson CN, Lacy MQ, Milone G, Reece D, Vewsole DH y Hari P, on behalf of the Writing Committee, Center for Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, USA. “Comparable outcomes in secretory versus non-secretory multiple myeloma patients following autologous hematopoietic stem cell transplantation”. Biol Blood Marrow Transp Oct 14 (1) 1134-40,2008.
Bashey A, Perez W, Zhang MJ, Anderson K, Ballen K, Berenson J, Fonseca R, Freytes C, Gale RP, Gibson J, Giralt S, Kyle R, Lazarus H, Maharaj D, McCarthy P, Milone G, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole D, Hari P, on behalf of the Plasma Cell Disorders Working Committee. “Syngeneic hematopoietic stem cell transplantation for multiple myeloma: A comparison to autologous transplantation”. Biol Blood Marrow Transplant 14:1118-24, 2008.
Smith SM, van Besien K, Carreras J, Bashey A, Cairo MS, Freytes CO, Gale RP, Hale GA, Hayes-Lattin B, Holmberg LA, Keating A, Maziarz RT, McCarthy PJ, Navarro WH, Pavlovsky S, Schouten HC, Seftel M, Wiernik PH, Vose JM, Lazarus HM, Hari P. “Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant”. Biol Blood and Marrow Transplant 14:904-912, 2008.
2007
Franklin J, Pluetschow A, Paus M, Specht L, Anselmo AP, Aviles A, Biti G, Bogatyreva T, Bonadonna G, Brillant C, Cavalieri E, Diehl V, Eghbali H, Ferme C, Henry-Amar M, Hoppe R, Howard S, Meyer R, Niedzwiecki D, Pavlovsky S, Radford J, Raemaekers J, Ryder D, Schiller P, Shakhtarina S, Valaguss P, Wilimas J and Yahalom J. “Second malignancy risk associated with treatment for Hodgkin Lymphoma: meta-analysis of the randomized trials”. Annals of Oncology Vol 17 Nº12 Pag 1749-1760,2007.
Ferreri AJ, Dognini GP, Campo E, Willemze R, Seymour JF, Bairey O, Martelli M, De Renzo A, Doglioni C, Montalbán C, Tedeschi A, Pavlovsky A, Morgan S, Uziel L, Ferracci M, Ascani S, Gianelli U, Patriarca C, Facchetti F, Zucca E, Cavalli F, and Ponzoni M. (on behalf of the International Extranodal Lymphoma Study Group I.E.L.S.G.). “Variations in clinical presentation, frequency of haemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions” Haematologica/The Hematology Journal 92, 486-492, 2007.
Sackmann Massa F, Martínez Rolón J, Pavlovsky S. Myelofibrosis with myeloid metaplasia in a patient with relapsed Hodgkin´s lymphoma who underwent autologous hematopoietic stem cell transplantation. Hematology 12 (6) 487-488, 2007
2006
Navarro WH, Loberiza Jr FR, Bajorunaite R, Armitage JO, Ballen K, Bashey A, Bredeson CN, Carreras J, Freytes CO, Gibson J, Hale GA, Horowitz MM, Lazarus HM, LeMaistre CF, Lister J, Marks D, Martino R, Maziarz RT, Pavlovsky S, Schiller G, Schouten HC, Stadtmauer E, van Besien K, Vose JM, Rizzo JD. Impact of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 12: 541-551,2006.
Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA., Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary John D, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, de Pauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano GE, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, HospenthalDurane R, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH., Knapp K, Kontoyiannis DP, Krcmery VC, Robert L, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA., Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela
JL, Coleman R, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobe J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano AM, Shahe V, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL and Zaoutis T. “Clinical Research in the Lay Press: Irresponsible Journalism Raises a Huge Dose of Doubt”. Clinical Infectious Diseases 2006;43:1031–9.
Jones J, Avritscher E, Cooksley C, Bekele B, Michelet M, Elting L. “Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer”. Review Article Support Care Cancer 14:505-515, 2006.
Ferreri AJ, Dognini GP, Campo E, Zucca E, Martelli M, De Renzo A, Doglioni C, Ferracci M, Montalban C, Tedeschi A, Pavlovsky A, Morgan A, Uziel L, Ascani S, Gianelli U, Patriarca C, Facchetti F, Mazzuchelli L, Cavalli F and Ponzoni M, on behalf of the Extranodal Lymphoma Study Group (I. E. L.S.G.) “Clinical features of the “Western” and “Asian” forms of intravascular Lymphoma (IVL) varies according to the prescence of Hemofagocytic Syndrome (HPS) and not to the geographical area”.
Monreal M, Pardo ML, Pavlovsky MA, Fernandez I, Corrado C, Giere I, Sapia S, Pavlovsky S. “ Increased Immature Hematopoietic Progenitor Cells CD34+ / CD38 dim in Myelodysplasia. Clinical Cytometry”. Cytometry Part B 70B:63-70, 2006.
Aiello E, Dignani MC, De Vedia L, Devoto F, Lorenzo H. “Costo efectividad de voriconazol versus anfotericina B deoxicolato en el tratamiento inicial de aspergilosis invasiva”. Rev Panam Infectol 8(1):18-25, 2006
Tallman MS, Perez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, Garcia JJ, Ilhan O, Laughlin MF, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Keating A, Weisdorf DJ, Horowitz MM. “Pretransplant consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission”.
Biol Blood Marrow Transplant Feb;12(2):204-16, 2006.
Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D, Walewski J, Zinzani PL, Stahel R, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Lehltinen T, Lopez-Guillermo A, Corrado C, Scheliga A, Milpied N, Mendila M, Rashford M, Kuhnt E, Loeffler M, for the MabThera International Trial (MinT) Group.
“CHOP-like chemotherapy plus Rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MinT) Group”. Group.Lancet Oncol 7: 379-91, 2006
Durie B, Harousseau JL, San Miguel J, Blade, J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G and Rajkumar SV on behalf of the International Myeloma Working Group.(Dr. S. Pavlovsky es miembro de este Grupo). International Uniform Response Criteria for Multiple Myeloma. Leukemia (leading article)1-7, 2006.
Vesole DH, Pérez WS, Akasheh M, Boudreau C, Reece DE, Bredeson CN, Bashey A, Brunvand MW, Dispenzieri A, Freytes CO, Gale RP, Gibson J, Giralt SA, Holland HK, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Schiller G, Siegel D, Wiernik PH. High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: A Center for International Blood and Marrow Transplant Research study. Mayo Clinic Proc. 81;880-888, 2006
subir |
